Ads
related to: eisai epilepsy drug- About Leqembi
Learn more about the treatment
option & how it works.
- Getting Started
Find treatment tips to get started
with Leqembi.
- Support & Resources
View patient support info and
downloadable resources on site.
- Leqembi Companion
Your online partner designed to
support you during treatment.
- Leqembi Care Partner
Explore tips for supporting
patients who are taking Leqembi.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Leqembi
Search results
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
Benzinga via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals Inc (NASDAQ: CPRX) agreed to acquire the U.S. rights to Eisai Co Ltd's...
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
Investor's Business Daily· 1 year agoCatalyst Pharmaceuticals added a second product to its lineup Wednesday with a $160 million deal for...
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals (CPRX) receives a notice letter stating that Teva Pharmaceuticals has filed...
5 Stocks to Buy as the Drug Industry Rebounds in 2023
Zacks via Yahoo Finance· 1 year agoInnovation is expected to continue driving growth in the Medical-Drugs industry in 2023. CPRX, KALV,...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 3 weeks agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted earnings of 38 cents per share for the first...
12 Best Performing NASDAQ Stocks in 2022
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss 12 best performing NASDAQ stocks in 2022. If you want to see more stocks in this selection, check out 5 Best Performing...
Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?
Zacks via Yahoo Finance· 9 months agoIt has been about a month since the last earnings report for Catalyst Pharmaceutical (CPRX). Shares...
Top Picks 2023- Catalyst Pharmaceuticals CPRX
MoneyShow via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals (CPRX) is a small-cap biopharma company focused on in-licensing, developing and commercializing novel medicines to treat rare diseases. It has a market cap of just under ...
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
TipRanks via Yahoo Finance· 3 months agoBuilding on the momentum from last year, this year’s market performance follows a similar pattern....
Ads
related to: eisai epilepsy drug
